Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy

ClinicalTrials.gov ID: NCT03227224

Public ClinicalTrials.gov record NCT03227224. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 3:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Adaptive Dose-Finding Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Subjects With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy

Study identification

NCT ID
NCT03227224
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Janssen Research & Development, LLC
Industry
Enrollment
287 participants

Conditions and interventions

Interventions

  • JNJ-42847922 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 15, 2017
Primary completion
Jan 11, 2019
Completion
Jan 18, 2019
Last update posted
Apr 28, 2025

2017 – 2019

United States locations

U.S. sites
33
U.S. states
10
U.S. cities
27
Facility City State ZIP Site status
California Pharmaceutical Research Institute, Inc. Anaheim California 92804
Catalina Research Institute Chino California 91710
Synergy Clinical Research Center Of Escondido Lemon Grove California 91945
Asclepes Research Panorama City California 91402
Sharp Mesa Vista Hospital San Diego California 92123
SF-Care, Inc San Rafael California 94901
Collaborative NeuroScience Network Torrance California 90502
Elite Clinical Trials Wildomar California 92595-7007
Sarkis Clinical Trials Gainesville Florida 32607
Velocity Clinical Research, Hallandale Beach Hallandale Florida 33009
Clinical NeuroScience Solutions Inc Jacksonville Florida 32256
Innovative Clinical Research Inc Lauderhill Florida 33319
Qps-Mra, Llc Miami Florida 33143
Galiz Research Miami Springs Florida 33166
Behavioral Clinical Research , Inc North Miami Florida 33162
Clinical NeuroScience Solutions Inc Orlando Florida 32801
Compass Research LLC Orlando Florida 32806
Emory University Atlanta Georgia 30022
Radiant Research, Inc. Atlanta Georgia 30328
Atlanta Center for Medical Research Atlanta Georgia 30331
NeuroTrials Research, Inc. Atlanta Georgia 30342
Chicago Research Center Chicago Illinois 60634
Great Lakes Clinical Trials Chicago Illinois 60640
Joliet Center for Clinical Research Joliet Illinois 60435
Clinilabs New York New York 10019
Richmond Behavioral Associates Staten Island New York 10312
Clinical Trials of America Winston-Salem North Carolina 27103
Wake Forest Baptist Medical Center Winston-Salem North Carolina 27157
Neuro Behavioral Clinical Research Canton Ohio 44708
Midwest Clinical Research Center Dayton Ohio 45417
Suburban Research Associates Media Pennsylvania 19063
Family Psychiatry of The Woodlands The Woodlands Texas 77381
Core Clinical Research Everett Washington 98201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 68 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03227224, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 28, 2025 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03227224 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →